| Literature DB >> 29695993 |
Runsen Chen1,2,3, Amy Gillespie3, Yanhui Zhao4, Yingjun Xi1,2, Yanping Ren1, Loyola McLean5,6,7.
Abstract
Background: Survivors of complex childhood trauma (CT) such as sexual abuse show poorer outcomes compared to single event trauma survivors. A growing number of studies investigate Eye Movement Desensitization and Reprocessing (EMDR) treatment for posttraumatic stress disorder (PTSD), but no systematic reviews have focused on EMDR treatment for CT as an intervention for both adults and children. This study therefore systematically reviewed all randomized controlled trials (RCTs) evaluating the effect of EMDR on PTSD symptoms in adults and children exposed to CT.Entities:
Keywords: EMDR; PTSD symptoms; childhood trauma; children and adult; complex trauma; systematic review
Year: 2018 PMID: 29695993 PMCID: PMC5904704 DOI: 10.3389/fpsyg.2018.00534
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1Preferred reporting items for systematic reviews and meta-analysis (PRISMA) flow diagram for search strategy and supply selection process.
Platinum Standard (PS) scores for EMDR studies.
| Edmond et al., | 0.5 | 1 | 0.5 | 0 | 1.0 | 1.0 | 1.0 | 1.0 | 0 | 0 | 1.0 | 1.0 | 1.0 | 9 |
| Jaberghaderi et al., | 0.5 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | 1.0 | 0.5 | 1.0 | 0.5 | 1.0 | 8.5 |
| Farkas et al., | 0.5 | 1 | 1 | 1 | 0.5 | 1.0 | 0.5 | 0 | 1.0 | 1.0 | 1.0 | 0.5 | 0 | 9 |
| Scheck et al., | 0.5 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | 0 | 0.5 | 0 | 1.0 | 0.5 | 1.0 | 9 |
| Soberman et al., | 1 | 1 | 0.5 | 0 | 1.0 | 0.5 | 0.5 | 0 | 1.0 | 0 | 0.5 | 0.5 | 0 | 6.5 |
| van der Kolk et al., | 1 | 1 | 1 | 0.5 | 1.0 | 1.0 | 0.5 | 0 | 0.5 | 0.5 | 1.0 | 1.0 | 1.0 | 10 |
EMDR, Eye movement desensitization and reprocessing; #1 clearly defined target symptoms (0, no clear diagnosis or symptom definition; 0.5, not all participants meet target symptom criteria; 1.0, all participants met target symptom criteria); #2 reliable and valid measures (0, did not use reliable and valid measures; 0.5, measures used inadequate to measure change; 1.0, reliable, valid, and adequate measures used); #3 use of blind evaluators (0, assessor was therapist; 0.5, assessor was not blind; 1.0, assessor was blind and independent); #4 information regarding an assessor's training (no training in administration of instruments used in the study); #5 manualized, replicable and specific treatment (0, treatment was not replicable or specific; 0.5, treatment replicable and specific but not standard EMDR protocol; 1.0, treatment followed EMDR training manual),; #6 random assignment (0, assignment not randomized; 0.5, only one therapist or other semi-randomized designs; 1.0, unbiased assignment to treatment); #7 treatment adherence (0, treatment fidelity poor; 0.5, treatment fidelity variable or self-monitored by therapist only; 1.0, treatment fidelity independently checked and adequate); #8 non-confounded conditions [0, most participants exposed to confounds with no control for variables; 1.0, confounds nonexistent or controlled for (e.g., exclusion, matched assignment, etc.)]; #9 use of multimodal measures (0, self-report measures only; 0.5, self-report plus interview or physiological or behavioral measures; 1, self-report plus two or more other types of measures); #10 length of treatment (0, 1–6 sessions; 0.5, 7–10 sessions; 1.0, 11+sessions); #11 level of therapist training (0, no qualifications for treating clinicians provided; 0.5, qualifications for treatment group, clinicians provided; 1.0, qualifications for treatment and comparative group, clinicians provided); #12 use of a control group (0, no use of a wait control/comparison group; 0.5, use of a comparison group but no control; a.0, use of a no-treatment control group); #13 effect size reporting (0, no effect size reported; 1.0, effect size reported).
Study characteristics of included studies.
| Edmond et al., | Routine individual treatment | 20/20 | Sexual abuse | Adultslatha 18–35 | 100% | 6 | Post-treatmentlatha 3 months | IES | Depression-BDI | 9 |
| Delayed EMDR treatment | 20/19 | |||||||||
| Jaberghaderi et al., | CBT | 7/7 | Sexual abuse | Childrenlatha 12–13 | 100% | 4–8 | 2 weeks post-treatment | CROPS | N/A | 8.5 |
| Farkas et al., | Routine individual/ group therapy | 19/21 | Maltreatment | Childrenlatha Mean = 14.6 | 62.5% | 12 | Post-treatment | DISC-PTSD symptoms | Depression-TSCC | 9 |
| Scheck et al., | Active listening | 30/30 | Mixed childhood abuse | Adultslatha 16-25 | 100% | 2 | Post-treatment | IES | Depression-BDI | 9 |
| Soberman et al., | Treatment as usual | 14/15 | Multiple childhood traumas | Childrenlatha 10–16 (mean 13.35) | 0 | 3 | Post-treatment | IES | N/A | 6.5 |
| van der Kolk et al., | Pill Placebo | 11/14 | Sexual and physical abuse | Adultslatha 18–65 (mean 36.1) | 83% | 8 | Post-treatment | CAPS | N/A | 10 |
| Fluoxetine | 11/10 |
Results from included studies for measures of PTSD symptoms.
| Edmond et al., | Routine individual treatment | Post-treatment | ||||||
| Delayed EMDR | Post-treatment | |||||||
| Jaberghaderi et al., | CBT | Post-treatment | Post-treatment | |||||
| Farkas et al., | Routine individual/ group therapy | Post-treatment | Post-treatment | |||||
| Scheck et al., | Active listening | Post-treatment | Post-treatment | |||||
| Soberman et al., | Treatment as usual | Post-treatment | Post-treatment | Post-treatment | ||||
| van der Kolk et al., | Pill Placebo | Post-treatment | ||||||
| Fluoxetine | Post-treatment |
indicate statistically significant findings.